Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem in Pediatric Subjects With Complicated Intra-Abdominal Infection
Conditions
Interventions
Ceftolozane/Tazobactam
Metronidazole
+2 more
Locations
50
United States
Children's Hospital - Los Angeles ( Site 2508)
Los Angeles, California, United States
Children's Hospital of Orange County ( Site 2502)
Orange, California, United States
Rady Children's Hospital-San Diego ( Site 2505)
San Diego, California, United States
Baptist Medical Center/Wolfson Children's Hospital ( Site 2521)
Jacksonville, Florida, United States
Tufts Medical Center-Floating Hospital for Children ( Site 2516)
Boston, Massachusetts, United States
St. Louis Children's Hospital ( Site 2511)
St Louis, Missouri, United States
Start Date
April 3, 2018
Primary Completion Date
March 16, 2020
Completion Date
March 16, 2020
Last Updated
May 6, 2023
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions